Time-course of sTREM (soluble triggering receptor expressed on myeloid cells)-1, procalcitonin, and C-reactive protein plasma concentrations during sepsis

被引:267
作者
Gibot, S [1 ]
Cravoisy, A
Kolopp-Sarda, MN
Béné, MC
Faure, G
Bollaert, PE
Levy, B
机构
[1] Hop Cent, Serv Reanimat Med, Nancy, France
[2] Fac Med, Immunol Lab, Nancy, France
关键词
sepsis; procalcitonin; soluble triggering receptor expressed on myeloid cells-1;
D O I
10.1097/01.CCM.0000159089.16462.4A
中图分类号
R4 [临床医学];
学科分类号
1002 [临床医学]; 100602 [中西医结合临床];
摘要
Objective: To describe the course of plasma sTREM (soluble triggering receptor expressed on myeloid cells)-1, procalcitonin (PCT), and C-reactive protein (CRP) concentrations during sepsis and their clinical informative value in predicting outcome. Design: Prospective, noninterventional study. Setting: Medical adult intensive care unit at a university hospital in France. Patients: Sixty-three critically ill patients with sepsis, severe sepsis, or septic shock. Interventions: None. Measurements and Main Results: Soluble TREM-1 concentrations were significantly lower at admission in nonsurvivors (n = 21) than in survivors (n = 42) (94 [30-258] vs. 154 [52-435] pg/mL, p = .02), whereas PCT levels were higher among nonsurvivors (19.2 [0.3-179] vs. 2.4 (0-254) pg/mL, p = .001). CRP levels did not differ between the two groups of patients. Plasma PCT and CRP decreased during the 14-day period of study in both survivors and nonsurvivors. Conversely, sTREM-1 plasma concentrations remained stable or even increased in nonsurviving patients and decreased in survivors. An elevated baseline sTREM-1 levet was found to be an independent protective factor with an odds of dying of 0.1 (95% confidence interval, 0.1-0.8). Conclusion: A progressive decline of plasma sTREM-1 concentration indicates a favorable clinical evolution during the recovery phase of sepsis. In addition, baseline sTREM-1 level may prove useful in predicting outcome of septic patients.
引用
收藏
页码:792 / 796
页数:5
相关论文
共 21 条
[1]
HIGH SERUM PROCALCITONIN CONCENTRATIONS IN PATIENTS WITH SEPSIS AND INFECTION [J].
ASSICOT, M ;
GENDREL, D ;
CARSIN, H ;
RAYMOND, J ;
GUILBAUD, J ;
BOHUON, C .
LANCET, 1993, 341 (8844) :515-518
[2]
DEFINITIONS FOR SEPSIS AND ORGAN FAILURE AND GUIDELINES FOR THE USE OF INNOVATIVE THERAPIES IN SEPSIS [J].
BONE, RC ;
BALK, RA ;
CERRA, FB ;
DELLINGER, RP ;
FEIN, AM ;
KNAUS, WA ;
SCHEIN, RMH ;
SIBBALD, WJ .
CHEST, 1992, 101 (06) :1644-1655
[3]
Cutting edge: Inflammatory responses can be triggered by TREM-1, a novel receptor expressed on neutrophils and monocytes [J].
Bouchon, A ;
Dietrich, J ;
Colonna, M .
JOURNAL OF IMMUNOLOGY, 2000, 164 (10) :4991-4995
[4]
TREM-1 amplifies inflammation and is a crucial mediator of septic shock [J].
Bouchon, A ;
Facchetti, F ;
Weigand, MA ;
Colonna, M .
NATURE, 2001, 410 (6832) :1103-1107
[5]
Brunkhorst FM, 2000, INTENS CARE MED, V26, pS148, DOI 10.1007/BF02900728
[6]
Plasma procalcitonin and C-reactive protein in acute septic shock: Clinical and biological correlates [J].
Claeys, R ;
Vinken, S ;
Spapen, H ;
Elst, KV ;
Decochez, K ;
Huyghens, L ;
Gorus, FK .
CRITICAL CARE MEDICINE, 2002, 30 (04) :757-762
[7]
Diagnostic and prognostic value of procalcitonin in patients with septic shock [J].
Clec'h, C ;
Ferriere, F ;
Karoubi, P ;
Fosse, JP ;
Cupa, M ;
Hoang, P ;
Cohen, Y .
CRITICAL CARE MEDICINE, 2004, 32 (05) :1166-1169
[8]
TREM-1 (triggering receptor expressed on myeloid cells): A new player in acute inflammatory responses [J].
Colonna, M ;
Facchetti, F .
JOURNAL OF INFECTIOUS DISEASES, 2003, 187 :S397-S401
[9]
Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock [J].
Dellinger, RP ;
Carlet, JM ;
Masur, H ;
Gerlach, H ;
Calandra, T ;
Cohen, J ;
Gea-Banacloche, J ;
Keh, D ;
Marshall, JC ;
Parker, MM ;
Ramsay, G ;
Zimmerman, JL ;
Vincent, JL ;
Levy, MM .
INTENSIVE CARE MEDICINE, 2004, 30 (04) :536-555
[10]
Soluble triggering receptor expressed on myeloid cells and the diagnosis of pneumonia [J].
Gibot, S ;
Cravoisy, A ;
Levy, B ;
Bene, MC ;
Faure, G ;
Bollaert, PE .
NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (05) :451-458